Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fusion Pharmaceuticals Inc (FUSN)

Fusion Pharmaceuticals Inc (FUSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fusion Pharmaceuticals Inc 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 CAN

fusionpharma.com P: 289-799-0891

Description:

Fusion Pharmaceuticals Inc. is a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines. The compnay's lead program includes FPI-1434, which is in clinical trial. Fusion Pharmaceuticals Inc. is based in Hamilton, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,833,043
Enterprise Value, $K 1,805,893
Shares Outstanding, K 85,060
Annual Sales, $ 2,070 K
Annual Net Income, $ -94,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -28,180 K
EBIT, $ -99,240 K
EBITDA, $ -97,890 K
60-Month Beta -0.69
% of Insider Shareholders 7.75%
% of Institutional Shareholders 72.85%
Float, K 78,468
% Float 92.25%
Short Volume Ratio 0.06

Growth:

1-Year Return 339.80%
3-Year Return 164.42%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 05/07/24
Next Earnings Date 05/09/24
Earnings Per Share ttm -1.47
EPS Growth vs. Prev Qtr -2.56%
EPS Growth vs. Prev Year 11.11%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FUSN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.74%
Return-on-Assets % -36.87%
Profit Margin % -4,584.54%
Debt/Equity 0.16
Price/Sales 885.15
Price/Cash Flow N/A
Price/Book 7.58
Book Value/Share 3.07
Interest Coverage -2.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar